Company Filing History:
5 out of 218 
1 out of 1,536 
Years Active: 1985-2007
Title: The Innovative Contributions of Christopher P Johnson, III
Introduction
Christopher P Johnson, III, based in Richmond, VA, is a distinguished inventor known for his impactful contributions to the field of pharmaceuticals. With a total of six patents to his name, he has made remarkable strides in developing innovative processes and compounds.
Latest Patents
Christopher's latest patents reflect his expertise in chemical processes and pharmaceutical development. One notable patent is for a "Process for making 5,11-Dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3′-e][1,4]diazepin-6-one." He has also developed an "Improved process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3′-e][1,4]diazepin-6-one." Additionally, he has disclosed novel heterocyclic methanols under the patent for "Aryloxymethyl derivatives of nitrogenous heterocyclic methanols," which exhibit complex structures that could lead to significant advancements in the pharmaceutical industry.
Career Highlights
Christopher has enjoyed a successful career with notable companies such as A. H. Robins Company and Boehringer Ingelheim International GmbH. His extensive experience in these organizations has honed his skills as an inventor and has contributed to the development of innovative pharmaceutical solutions.
Collaborations
Throughout his career, Christopher has collaborated with esteemed colleagues, including James R Shanklin, Jr. and Saeed Ahmad. These collaborations have fostered a productive environment for innovation and the advancement of pharmaceutical research, leveraging their collective expertise to achieve groundbreaking results.
Conclusion
Christopher P Johnson, III stands out as a notable inventor in the pharmaceutical field, with a proven track record of innovation and collaboration. His patents not only highlight his inventiveness but also contribute significantly to the advancement of medical science, showcasing the importance of continued research and development within the industry.